A Study to Evaluate the Efficacy and Safety of Glecaprevir/Pibrentasvir in Adults With Chronic Hepatitis C Virus Genotype 1 - 6 Infection and Renal Impairment
NCT03069365
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
101
Enrollment
INDUSTRY
Sponsor class
Conditions
Hepatitis C Virus (HCV)
Interventions
DRUG:
Glecaprevir/pibrentasvir
Sponsor
AbbVie